Neuland Laboratories, meeting of board of directors is scheduled to be held on April 9, 2018, to consider a proposal for fund raising.

The company will raise funds via issue of equity shares or equity linked securities such as warrants or convertible securities including but not limited to through preferential issue and/or qualified institutions placement or through any other permissible mode and /or combination thereof as may be considered appropriate,

Further, it is subject to various regulatory/statutory approvals as may be applicable, including approval of the shareholders at a general meeting or via postal ballot.

Read EquityPandit’s Technical Analysis of Indian Stock Market